Corporate Magazine 2012 - Boehringer Ingelheim

usiness year 2012group management reportour patients and employees and their families is to us.This commitment is actively supported and implementedthrough our participation in a large number of projectsaimed at helping people in particular need in the countriesand regions in which we are active as a company.The global partnership “Making More Health” betweenBoehringer Ingelheim and Ashoka, an international nongovernmentalorganisation (NGO), has been a major partof our social commitment since 2011. The aim of theprogramme is to identify and provide three years of supportfor 50 social entrepreneurs whose concepts are furtheringsustainable solutions in the area of health. Theseare people who are looking to make a long-term, positivechange to society and are willing to work energeticallyto achieve this. The company currently supports35 social entrepreneurs in 23 countries around the world.In addition to the financial support provided by the group,Boehringer Ingelheim’s employees actively participate inlocal projects. The participants in the Global ManagementDevelopment Programme (GMDP) even have theopportunity to accompany the activities of a social entrepreneuron-site for a certain time. Sample projects includean improved interpreting service for hearing-impairedpeople in Germany and an innovative approach tohelping people in eastern Africa who are not in regularemployment to obtain access to health insurance.2012 also saw the continuation of the global informationcampaign “1 Mission 1 Million® – Getting to the Heartof Stroke”. Boehringer Ingelheim launched this initiativein 2010 and has since supported 32 projects selected bythe public that are aimed at improving the understandingof atrial fibrillation and the associated risk of stroke,as well as the public perception.In the 2012 financial year, Boehringer Ingelheim enteredinto a partnership with the global online donation portal“ammado”. This platform allows individuals and organisationsto collect donations independently and aroundthe world for their information projects with regard tostroke prevention, for which Boehringer Ingelheim providesfinancial support of up to EUR 2,500 per project.2012 also saw the start of efforts to create a global petitionto support the work of the World Trade Organization,its member states and other health authorities andto help atrial fibrillation to be recognised around theworld as a relevant risk factor for strokes.Boehringer Ingelheim has been an active supporter ofresearch, science and culture for many years. Long-termpartnerships with academic institutions serve to underlinethe group’s systematic focus on research and development.In addition to supporting and sponsoring scientificactivities, the group presents scientists with awards,such as the Boehringer Ingelheim FENS Research Awardfor neuroscience.NET ASSETS, FINANCIALPOSITION AND RESULTSFROM OPERATIONSResults from operationsThe achievement of long-term, sustainable success of thecompany, accompanied by stable profits and solid financing,is the foundation for securing the independence ofthe group of companies and is at the centre of BoehringerIngelheim’s strategic orientation. As in previous years,we based our actions on these principles last year. TheComponents of growth in net sales (as %) 2012 2011 2010 2009 2008Price/quantity/new introductions 6.3 6.3 — 6.2 6.6 9.7Acquisitions and sale of business 0.0 — 0.1 0.2 0.1 — 0.2Currency effect 5.2 — 1.6 4.9 3.0 — 3.6Business and operating environment / Net assets, financial position and results from operations31